Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

4.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.6K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Longitudinal Analysis of HIV-2 Proviral DNA Reveals Archived Protease Inhibitor Resistance and Reservoir Evolution over Eight Years.

International journal of molecular sciences·2026
Same author

Analysis of Histostructural Modifications in the Ocular Surface of Patients With Chronic Glaucoma.

Investigative ophthalmology & visual science·2026
Same author

The protective role of SIRT1 in cardiovascular disease: from molecular mechanisms to potential therapeutic strategies.

Expert opinion on therapeutic targets·2026
Same author

Generation and ex vivo characterization of a full-thickness substitute of the human urethra by tissue engineering.

Bioengineering & translational medicine·2026
Same author

Targeting Pyruvate Kinase M2: Signal Transduction Pathways and Exploration of Cancer Therapeutic Strategies.

The AAPS journal·2026
Same author

Editorial: Community Series in Engineered Immune Cells in Cancer Immunotherapy (EICCI), volume II.

Frontiers in immunology·2026

相关实验视频

Updated: Jan 12, 2026

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

13.8K

黑色素通过降低ABCB1表达和调节线粒体功能来克服癌症的多药性耐药性.

Alba López-Rodríguez1,2,3, Laura Martinez-Ruiz1,2,3, Raquel Morales-Gallel4,5

  • 1Institute of Biotechnology, Biomedical Research Center, Health Sciences Technology Park, University of Granada, Granada, Spain.

Journal of pineal research
|November 5, 2025
PubMed
概括

黑色素通过促进线粒体反应性氧物种 (ROS) 来对抗癌症中的多药性耐药性 (MDR),这限制了排泄的ATP. 这增强了ABCB1过度表达细胞的化学敏感性,并减少了瘤的生长.

关键词:
这是一种P-glycoprotein蛋白.灭症 (apoptosis) 是一种死亡的过程.头部和部癌症 头部和部癌症黑激素是什么意思 黑激素是什么意思线粒体中的线粒体.多种药物耐药性多种药物耐药性有活性氧物种的反应性氧物种.

更多相关视频

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

19.1K
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

3.5K

相关实验视频

Last Updated: Jan 12, 2026

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module
10:39

Using Mouse Mammary Tumor Cells to Teach Core Biology Concepts: A Simple Lab Module

Published on: June 18, 2015

13.8K
Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen
19:44

Enhancement of Apoptotic and Autophagic Induction by a Novel Synthetic C-1 Analogue of 7-deoxypancratistatin in Human Breast Adenocarcinoma and Neuroblastoma Cells with Tamoxifen

Published on: May 30, 2012

19.1K
Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
14:51

Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype

Published on: June 17, 2022

3.5K

科学领域:

  • 在瘤学瘤学.
  • 生物化学 生物化学
  • 线粒体生物学 线粒体生物学

背景情况:

  • 多药性耐药性 (MDR) 是癌症化疗中的一个重大障碍.
  • 像ABCB1这样的ATP结合盒 (ABC) 载体的过度表达是MDR的关键驱动因素.
  • 新的策略对于克服由ABC传送器介导的阻力至关重要.

研究的目的:

  • 研究黑激素在癌细胞中克服ABCB1介导的MDR的机制.
  • 阐明线粒体功能的作用在黑激素的MDR逆转效应.
  • 评估黑激素作为抗化学抵抗的辅助疗法的潜力.

主要方法:

  • 评估了黑激素对头部和部状细胞癌 (CAL 27,SCC-9) 和过度表达ABCB1.1的乳腺癌 (MCF-7) 细胞系的影响.
  • 分析了黑激素对线粒体功能,活性氧物种 (ROS) 生产和ABCB1表达的影响.
  • 在CAL 27异种移植小鼠模型中评估了黑激素的疗效.

主要成果:

  • 黑色素治疗诱导了线粒体ROS的产生,削弱了化学抵抗.
  • 产生ROS导致NADH氧化为NADH+,限制了ATP可用性.
  • 黑色素降低了核附近的线粒体局部化,降低了ABCB1的表达,并在体内减少了瘤体积.

结论:

  • 黑色素通过调节线粒体新陈代谢和氧化还原平衡来增强ABCB1过度表达的癌细胞中的化学敏感性.
  • 黑色素抑制ABCB1表达的能力有助于克服MDR.
  • 黑色素显示承诺作为辅助疗法,以打击多药耐药性在癌症治疗.